Status:
COMPLETED
Safety and Effectiveness of the Medtronic Resting Heart Bypass System in Heart Surgery Patients
Lead Sponsor:
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Collaborating Sponsors:
Medtronic
Conditions:
Coronary Artery Bypass Surgery
Cardiopulmonary Bypass
Eligibility:
All Genders
30-85 years
Phase:
PHASE1
Brief Summary
The purpose of this study is to determine if the Medtronic Resting Heart Bypass system is safer and results in less inflammatory reaction than traditional bypass machines used in coronary artery bypas...
Detailed Description
Cardiopulmonary bypass (CPB) has played an extremely crucial role in coronary artery bypass grafting (CABG) surgery for the past five decades. During CABG, the CPB machine enables the surgeon to stop ...
Eligibility Criteria
Inclusion
- Consenting patients undergoing elective surgical coronary artery bypass grafting (CABG) with use of the cardiopulmonary bypass machine
Exclusion
- Patients unable to provide written informed consent
- Emergency CABG surgery
- Concomitant CABG + Valvular surgery
- Off-pump CABG surgery
Key Trial Info
Start Date :
November 1 2004
Trial Type :
INTERVENTIONAL
End Date :
February 1 2006
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00303641
Start Date
November 1 2004
End Date
February 1 2006
Last Update
August 28 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
London Health Sciences Centre, University Hospital
London, Ontario, Canada, N6A 5A5